• $132.7M
    Market Cap
  • -14.29%
    1-Year Change
  • Health Information Services
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 42
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

So-Young (SY) Q3 2025 Earnings Call Transcript

So-Young International reported significant growth in its branded aesthetic center business, with aesthetic treatment service revenues increasing 304.6% year-over-year. Despite strong membership growth and repeat customer metrics, the company experienced a net loss and declines in adjacent service segments.

11/17/2025, 8:05 AM • The Motley Fool

So-Young Shares Get A Makeover

So-Young International Inc. is shifting its business model from referring people to third-party clinics to operating its own facilities, which has led to a surge in its stock price in the last two weeks.

06/25/2025, 8:40 AM • Benzinga

Peers

Statistics

More
Day Range
$1.42
$1.57
$1.47
1-Year Range
$1.43
$5.87
$1.47
Latest Close$1.47
Change
-$0.09 (-6.46%)
Volume462,796
Market Cap$132.7M
Shares Outstanding84.8M
P/E (TTM)-0.50
Diluted EPS (TTM)-$3.11
Enterprise Value-$245.7M

Information as of 06/23/2026

Company Profile

SO-YOUNG INTERNATIONAL INC
https://www.soyoung.com
$132.7M
Market Cap
-$242.3M
Net Income
Sector: Healthcare
Industry: Health Information Services
East Tower, Poly Plaza, Beijing, China, 100012
86 10 8790 2012

So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive to minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems for urological treatments, and hydrodynamic-assisted liposuction systems for plastic surgery, as well as pneumatic liquid spray devices skin cleansing. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Beijing, China.

Key Executives

  • Xing Jin
  • Tao Yu
  • Vivian
  • Christian Arnell
  • Bei Wang

Current Ownership Distribution

  • Institutions230.7M (86.79%)
  • Mutual Funds30.5M (11.46%)
  • Insiders4.6M (1.75%)
  • Other0 (0.00%)